2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
555
Lymphoma
447
Precursor Cell Lymphoblastic Leukemia-Lymphoma
413
Lymphoma, Large B-Cell, Diffuse
348
Leukemia
346
Multiple Myeloma
336
Lymphoma, Non-Hodgkin
317
Leukemia, Myeloid, Acute
289
Leukemia, Lymphocytic, Chronic, B-Cell
286
Lymphoma, Follicular
241
Burkitt Lymphoma
217
Myelodysplastic Syndromes
211
Lymphoma, Mantle-Cell
202
Hodgkin Disease
193
Recurrence
155
Lymphoma, B-Cell, Marginal Zone
142
Melanoma
136
Lymphoma, Large-Cell, Immunoblastic
116
Neoplasms
109
Lymphoma, B-Cell
103
Neuroblastoma
101
Neoplasms, Plasma Cell
99
Ovarian Neoplasms
96
Triple Negative Breast Neoplasms
94
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
91
Myeloproliferative Disorders
87
Hematologic Neoplasms
87
Leukemia, Myeloid, Chronic-Phase
83
Leukemia, Myeloid, Accelerated Phase
80
Leukemia, Myelomonocytic, Chronic
78
Interventions
nirogacestat
8
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Imatinib Mesylate
3
Cryosurgery
3
X-Rays
2
Toremifene
2
Phantoms, Imaging
2
Blood Specimen Collection
2
vactosertib
1
trifluridine tipiracil drug combination
1
strattice
1
liposomal doxorubicin
1
entinostat
1
anlotinib
1
Vinblastine
1
Taxes
1
Tamoxifen
1
Surveys and Questionnaires
1
Sunitinib
1
Sulindac
1
Sorafenib
1
Sirolimus
1
Saline Solution
1
Radiotherapy
1
Radiofrequency Ablation
1
Pregnancy
1
Oxaliplatin
1
Methotrexate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Desmoid Tumors
×
Cyclophosphamide
×
Clear all
NCT01046487
2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1
Completed
26 enrolled